187 related articles for article (PubMed ID: 33096896)
41. Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment.
Rajaeinejad M; Parhizkar-Roudsari P; Khoshfetrat M; Kazemi-Galougahi MH; Mosaed R; Arjmand R; Mohsenizadeh SA; Arjmand B
Cardiovasc Toxicol; 2024 Feb; 24(2):184-198. PubMed ID: 38324115
[TBL] [Abstract][Full Text] [Related]
42. Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology.
Quagliariello V; Passariello M; Bisceglia I; Paccone A; Inno A; Maurea C; Rapuano Lembo R; Manna L; Iovine M; Canale ML; Scherillo M; Ascierto PA; Gabrielli D; De Lorenzo C; Maurea N
Front Cardiovasc Med; 2024; 11():1232269. PubMed ID: 38322766
[TBL] [Abstract][Full Text] [Related]
43. Coexistence of Left Atrial Tumor and Lung Cancer-The Key Role of an Individualized Approach.
Hawryszko M; Sławiński G; Jankowska H; Dorniak K; Kochańska A; Daniłowicz-Szymanowicz L; Lewicka E
Diagnostics (Basel); 2024 Jan; 14(2):. PubMed ID: 38248011
[TBL] [Abstract][Full Text] [Related]
44. Long-term cardiovascular mortality risk in patients with bladder cancer: a real-world retrospective study of 129,765 cases based on the SEER database.
Liao J; Zhou Z
Front Cardiovasc Med; 2023; 10():1142417. PubMed ID: 38028470
[TBL] [Abstract][Full Text] [Related]
45. Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects.
Cortellino S; Quagliariello V; Delfanti G; Blaževitš O; Chiodoni C; Maurea N; Di Mauro A; Tatangelo F; Pisati F; Shmahala A; Lazzeri S; Spagnolo V; Visco E; Tripodo C; Casorati G; Dellabona P; Longo VD
Nat Commun; 2023 Sep; 14(1):5529. PubMed ID: 37684243
[TBL] [Abstract][Full Text] [Related]
46. Boesenbergia rotunda displayed anti-inflammatory, antioxidant and anti-apoptotic efficacy in doxorubicin-induced cardiotoxicity in rats.
Zhang L; Jiang Q; Wang X; Jaisi A; Olatunji OJ
Sci Rep; 2023 Jul; 13(1):11398. PubMed ID: 37452121
[TBL] [Abstract][Full Text] [Related]
47. Emerging healthy lifestyle factors and all-cause mortality among people with metabolic syndrome and metabolic syndrome-like characteristics in NHANES.
Niu M; Chen J; Hou R; Sun Y; Xiao Q; Pan X; Zhu X
J Transl Med; 2023 Apr; 21(1):239. PubMed ID: 37005663
[TBL] [Abstract][Full Text] [Related]
48. Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes.
Hwang S; Kim SH; Yoo KH; Chung MH; Lee JW; Son KH
BMC Mol Cell Biol; 2022 Dec; 23(1):55. PubMed ID: 36517746
[TBL] [Abstract][Full Text] [Related]
49. Dietary Polyphenols as Prospective Natural-Compound Depression Treatment from the Perspective of Intestinal Microbiota Regulation.
Wang X; Yu J; Zhang X
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364464
[TBL] [Abstract][Full Text] [Related]
50. Combined association of triglyceride-glucose index and systolic blood pressure with all-cause and cardiovascular mortality among the general population.
Yu Y; Gu M; Huang H; Cheng S; Deng Y; Cai C; Chen X; Niu H; Ning X; Hua W
J Transl Med; 2022 Oct; 20(1):478. PubMed ID: 36266665
[TBL] [Abstract][Full Text] [Related]
51. Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.
Quagliariello V; Passariello M; Di Mauro A; Cipullo C; Paccone A; Barbieri A; Palma G; Luciano A; Buccolo S; Bisceglia I; Canale ML; Gallucci G; Inno A; De Lorenzo C; Maurea N
Front Cardiovasc Med; 2022; 9():930797. PubMed ID: 36158826
[TBL] [Abstract][Full Text] [Related]
52. Sodium-glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway.
Zhan X; Cheng L; Huo N; Yu L; Liu C; Liu T; Li G; Fu H
Front Cardiovasc Med; 2022; 9():908037. PubMed ID: 36148071
[TBL] [Abstract][Full Text] [Related]
53. Identification of immune-related key genes in the peripheral blood of ischaemic stroke patients using a weighted gene coexpression network analysis and machine learning.
Zheng PF; Chen LZ; Liu P; Pan HW; Fan WJ; Liu ZY
J Transl Med; 2022 Aug; 20(1):361. PubMed ID: 35962388
[TBL] [Abstract][Full Text] [Related]
54. A Glimpse of Inflammation and Anti-Inflammation Therapy in Diabetic Kidney Disease.
Liu C; Yang M; Li L; Luo S; Yang J; Li C; Liu H; Sun L
Front Physiol; 2022; 13():909569. PubMed ID: 35874522
[TBL] [Abstract][Full Text] [Related]
55. PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis.
Zhou M; Sun X; Wang C; Wang F; Fang C; Hu Z
Sci Rep; 2022 Jul; 12(1):11684. PubMed ID: 35804014
[TBL] [Abstract][Full Text] [Related]
56. Clinical Manifestations, Monitoring, and Prognosis: A Review of Cardiotoxicity After Antitumor Strategy.
Huang W; Xu R; Zhou B; Lin C; Guo Y; Xu H; Guo X
Front Cardiovasc Med; 2022; 9():912329. PubMed ID: 35757327
[TBL] [Abstract][Full Text] [Related]
57. Protective Effect of Crocin on Immune Checkpoint Inhibitors-Related Myocarditis Through Inhibiting NLRP3 Mediated Pyroptosis in Cardiomyocytes via NF-κB Pathway.
Zhang H; Lin J; Shen Y; Pan J; Wang C; Cheng L
J Inflamm Res; 2022; 15():1653-1666. PubMed ID: 35282269
[TBL] [Abstract][Full Text] [Related]
58. D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy.
Oikawa M; Yaegashi D; Yokokawa T; Misaka T; Sato T; Kaneshiro T; Kobayashi A; Yoshihisa A; Nakazato K; Ishida T; Takeishi Y
Front Cardiovasc Med; 2021; 8():807754. PubMed ID: 35127869
[TBL] [Abstract][Full Text] [Related]
59. Myocardial PD-L1 Expression in Patients With Ischemic and Non-ischemic Heart Failure.
Kushnareva E; Kushnarev V; Artemyeva A; Mitrofanova L; Moiseeva O
Front Cardiovasc Med; 2021; 8():759972. PubMed ID: 35096992
[No Abstract] [Full Text] [Related]
60. Applications of Extracellular Vesicles in Triple-Negative Breast Cancer.
St-Denis-Bissonnette F; Khoury R; Mediratta K; El-Sahli S; Wang L; Lavoie JR
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
